Patients with newly diagnosed multiple myeloma (NDMM) exhibit varying outcomes, with around 60% classified as intermediate-risk under the Revised International Staging System (R-ISS).

Read More> https://multiplemyeloma.pocn.com/diagnosis/study-revises-prognostic-staging-system-for-multiple-myeloma-enhancing-stratification-with-new-risk-factors/